Summary &horbar; The effect of synthetic human PTHrP (1 -34) or (107-111) fragments on bone loss was studied in rats, one month after ovariectomy (OVX). Four groups of 7-8-month-old rats were treated sc daily for 13 d with PTHrP (1-34) or (107)(108)(109)(110)(111) at the dose of 1 or 3 nmol/100 g body weight. Sham-operated (SHO) and control OVX rats received solvent alone. In our conditions, at the lowest dose, neither (1-34) nor (107-111 ) fragments had any significant effect. However, at the dose of 3 nmol/100 g daily for 13 3 d both treatments significantly increased femoral dry weight, ash weight, Ca content and densitometry of the femur. The effect of PTHrP (1-34) mainly resulted from increased cortical and trabecular bone (% recovery: 98.25 
INTRODUCTION
The action of parathyroid hormone (PTH) on the skeleton is paradoxical because it directly and indirectly affects bone formation and resorption (Parsons, 1976) . The first evidence that bone resorption is a direct response to PTH was obtained by Barnicot half a century ago (Barnicot, 1948) . Several studies have confirmed this result (Parsons, 1976 ). However, when PTH is intermittently administered at low doses, it is anabolic for bone in normal and osteoporotic rats (Burrows, 1938; Hock and Wood, 1991; Kimmel et al, 1993) , in adult dogs (Parsons and Reit, 1974) and in osteoporotic humans (Reeve et al, 1980) .
The discovery of PTH-related peptide (PTHrP) was the result of investigations into the mechanisms by which some cancers in humans (Suva et al, 1987; Mangin et al, 1988) or animals (Rosol et al, 1983) cause hypercalcemia without necessarily metastasizing to bone. PTHrP has similar effects to PTH on bone cells (Stewart et al, 1988; Thompson et al, 1988; Civitelli et al, 1989) . Although some studies indicate that the synthetic human PTHrP (hPTHrP) (1-34) fragment might be less potent that hPTH as an anabolic agent for bone in vivo (Fukayama et al, 1988; Hock et at, 1989) , hPTHrP (1-74) increases bone mass when injected at the dose of 1 or 2 nmol/100 g body weight/d for 12 d in young growing male rats (Weir et al, 1992) . From studies of the action of the hPTHrP (1-141) molecule on populations of osteoclasts disaggregated from neonatal rat bones, it has been shown that hPTHrP (1-141) had a direct effect on osteoclasts in inhibiting bone resorption, whereas no such inhibition was obtained with the synthetic amino-terminal peptides hPTHrP (1-34) and . This osteoclast inhibitory activity was localized to a carboxyl-terminal fragment: hPTHrP (107-139) (Fenton etal, 1991 a (Fenton et al, 1991 b (Sone et al, 1992) . Thus, in the present work, we have compared the effects of synthetic hPTHrP (1-34) and osteostatin on bone loss induced by ovariectomy in adult rats (Kalu, 1991 The Ca concentrations in bone, urine, feces and blood plasma were measured by atomic absorption spectrophotometry (Perkin Elmer 400). Phosphorus in urine and plasma was measured using a spectrocolorimeter (Secoman, Domont, France).
Analysis
The femoral bone density was measured at 19 9 uniform intervals (1/8 inch) from the distal to the proximal end using a Norland single photon absorptiometer and expressed per bone width for these sites.
After total dehydration the right tibia and the right femur were embedded in methyl methacrylate (Miller et al, 1989) . In order to characterize static cancellous bone, frontal sections of the distal femur were cut with a saw and stained with Von Kossa's reagent and analysed with an automated television microscope image analysis system, as previously described (Miller and Jee, 1975 were determined from the cross-section at the tibio-fibular junction. The sections were quantified using a digitizing tablet and a microcomputer with histomorphometry software (Anderson, 1982) . 
RESULTS
The OVX rats were food-restricted and so their body weight at death (395 ± 23 g) was no different from that of the SHO animals (412 ± 30 g).
The atrophied uterine horns (322 ± 18 mg (n = 35) vs1 1 107 ± 47 mg (n = 7); p < 0.01) confirmed successful ovariectomy in operated rats.
In our experimental conditions, no treatment had any significant effect upon either body weight at death or on plasma Ca (10.0 ± 0.5 mg/dl (n = 42; 6 groups of 7 animals)) and P concentrations (5.2 ± 0.8 mg/dl (n = 42; 6 groups of 7 animals)). The Ca (6.0 ± 1.3 mg/d; n = 294) and P urinary excretion (3.6 ± 1.1 mg/d; n = 294) were not significantly modified either (mean values (table III; fig 2) .
DISCUSSION
In our food-restricted rats, OVX did not induce a significant increase in body weight during the 43 d following surgery. However, similar skeletal changes have been demonstrated in OVX rats whether pair-fed, weight-matched or fed ad libitum and likewise pair-feeding has no qualitative effects on skeletal changes after OVX (Arjmandi et al, 1993) . The full length recombinant PTHrP molecule and its (1-34) amino-terminal fragment share the same effects on cytosolic Ca ion mobilization and adenylate cyclase activation in rat osteoblast-like cells (Donahue et al, 1989) . As shown by the daily Ca intake of each rat (about 270 mg), the 30 g of food (9 mg Ca/g diet) given daily to each animal were totally consumed. However, since our rats were not pair-fed, it is possible that subtle changes in urinary Ca and P excretion were not detected in the present study.
As previously reported (Kalu, 1991; Miller et al, 1991; Kimmel et al, 1993) (Weir et al, 1992 (Hock et al, 1989 ). In our experiment, the (1-34) fragment acted both at the trabecular (table III; fig 2) and the cortical levels as shown by the cortical surface at the tibiofibular junction (table II) . Murrills etal(1990) (1991 a, b) . This might partly explain why Sone et al (1992) found no effect in an attempt to inhibit murine calvarial resorption by osteostatin.
In conclusion, our results demonstrate 
